SNBL USA Signs Agreement with EPL, Inc.

SNBL USA increases its expert pathology services to better serve clients

Everett, WA - January 29, 2007 - SNBL USA, one of the nation’s leading preclinical testing companies, has entered into a Laboratory Services Agreement with Experimental Pathology Laboratories, Inc. (EPL), an industry leader in high-quality toxicologic pathology evaluation and consultation. This agreement, which took effect on January 1, 2007, allows SNBL USA to utilize EPL’s expert pathology services on an on-going basis which in turn expands SNBL USA’s ability to provide on-time, high quality study conduct for SNBL USA clients.

"We take great pride in providing the best service to our clients. This agreement enables SNBL USA to utilize EPL for various pathology services for any overflow work that we may experience moving forward. With our incredible, continuing growth, we understand that it is in our clients’ best interest to have pathology services ’on the ready’ for any overflow work that we would have to facilitate. By working with EPL we are in a position to provide the high quality service our clients have come to expect even during busy times," said James Klaassen, DVM, PhD, DACVP, SNBL USA Executive Director of Laboratory Services. "So while SNBL USA continues its growth, with the support of EPL, we will be able to continue to meet study deadlines in addition to providing the highest quality of customer service to our clients."

"SNBL USA came to us with clear requirements regarding the kind of pathology services they were looking for to support its client base," Jerry Hardisty, President of EPL said. "EPL is leading the way in providing expert pathology services and we are very proud that SNBL USA has chosen our services to have on retainer."

About EPL, Inc.

Founded in 1971, EPL, Inc. is the largest, truly independent organization offering experimental and toxicologic pathology services on a contract basis. Valued for its objectivity, expertise and responsiveness, EPL has become the toxicologic pathology solution for industry and government organizations nationwide. For more information, please visit www.epl-inc.com.

About SNBL USA, Ltd.

SNBL USA, Ltd. is a preclinical CRO that specializes in nonhuman primate (NHP) and small animal research. Study programs range from regulatory toxicology to customized study designs and disease models. Specialized programs include reproductive toxicology, safety pharmacology, immunotoxicology and carcinogenicity. SNBL USA’s Laboratory Services division intelligently applies extensive experience, comprehensive scientific capabilities, and modern technology to bring outstanding support to all client research. Through a commitment to investment and excellence, SNBL USA strives to offer the biotechnology and pharmaceutical industries unparalleled quality in both science and service. For additional information call 425.407.0121 or visit www.snblusa.com.